Publications by authors named "Nauryzbay Imanbayev"
Introduction: The gut microbiome maintains the mucus membrane barrier's integrity, and it is modulated by the host's immune system.
Aim: To detect the effect of microbiota modulation using probiotics, prebiotics, symbiotics, and natural changes on colorectal cancers (CRCs).
Methods: A PubMed search was conducted to retrieve the original and articles published in English language from 2010 until 2021 containing the following keywords: 1) CRCs, 2) CRCs treatment (i.
Objective: To determine the demographic and clinical characteristics of individuals diagnosed with colorectal cancer.
Methods: A retrospective study was conducted on 650 patients diagnosed with colorectal cancer in West Kazakhstan from 2019 to 2023. Statistical analysis was performed to explore the relationships between various factors and outcomes, using significance tests and regression techniques.
Article Synopsis
- The study investigates the significance of keloid-like collagen (KC) in the stroma of colorectal cancer, specifically looking at its impact on patient outcomes for TNM stage II/III cases.
- Researchers examined 175 tumors, categorizing them into two groups based on KC presence and finding that higher KC levels (type B) were associated with worse prognosis compared to lower levels (type A).
- The results indicate that KC is an independent predictor of 5-year recurrence-free survival, suggesting that assessing KC could help in evaluating patient risks following surgery.
The Role of Tumor Parenchymal and Stromal Ratios in Colorectal Cancer.
J Family Reprod Health
March 2024
Objective: To evaluate the implications and significant role of parenchymal and stromal ratio in colorectal cancer (CRC).
Materials And Methods: In our review, we involved English studies from common databases such as Web of Science, Scopus, Google Scholar, PubMed, and the Cochrane Library using the following keywords "colorectal cancer", "tumor stromal ratio", "tumor parenchymal ratio", and "prognostic marker" till December 2023.
Results: The majority of CRC patients are usually diagnosed at late stages, which may lead to missing out on the chance to get radical therapy.